Pure Global
NCT05466773

Hemodialysis Eating Education Intervention in Hemodialysis Patients

Hemodialysis Eating Education Intervention to Improve the Depression, Treatment Adherence, Cardiovascular Risks, Quality of Life, and Healthcare Utilization Among Hemodialysis Patients: A Quasi-experimental Design
Taipei Medical University·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hemodialysis Complication
Drug/Device/Intervention
Hemodialysis eating index (HDEI) base education intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Taipei Medical University
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 01, 2019
End date
Jun 30, 2022
Enrollment
141 participants
Primary outcome

Health Literacy

Summary

The investigator aim to evaluate the effect of training program on treatment adherence,
 quality of life, cardiovascular risk factors, depression, and healthcare utilization. The
 investigator conducted a quasi experimental study. The investigator also examine the effect
 of interaction between health literacy and training program on depression, treatment
 adherence, cardiovascular risk factors, quality of life, and healthcare utilization.
 
 The ultimate goal is to improve the dietary intake and dialysis outcomes for all hemodialysis
 patients in Taiwan. The investigator therefore will the SaaS dietary educational platform for
 this purpose.

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05466773
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05466773 through Pure Global AI's free database. This phase not specified trial is sponsored by Taipei Medical University and is currently Completed. The study focuses on Hemodialysis Complication. Target enrollment is 141 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.